The current understanding of the molecular determinants of inflammatory breast cancer metastasis

被引:0
|
作者
Galina S. Radunsky
Kenneth L. van Golen
机构
[1] Division of Hematology and Oncology,Department of Internal Medicine
[2] The University of Michigan Comprehensive Cancer Center,R4048 Kresge II, 200 Zina Pitcher Place
[3] The University of Michigan,undefined
来源
Clinical & Experimental Metastasis | 2005年 / 22卷
关键词
inflammatory breast cancer; metastasis; molecular profile;
D O I
暂无
中图分类号
学科分类号
摘要
Inflammatory breast cancer is a highly aggressive and metastatic form of locally advanced breast cancer that carries a significantly worse prognosis than non-inflammatory breast cancers. Unfortunately, the molecular basis of this deadly form of breast cancer has been understudied. Over the past 10 years new studies have begun to reveal a unique molecular profile of IBC shedding light on its unique ability to rapidly invade and metastasize via the dermal lymphatic system of the skin overlying the breast. The goal of this review is to introduce IBC to the reader and provide a brief overview of what is known about the metastatic mechanisms of the disease.
引用
收藏
页码:615 / 620
页数:5
相关论文
共 50 条
  • [21] Understanding molecular mechanism of cancer metastasis to the brain
    Jhanwar-Uniyal, Meena
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S56 - S56
  • [22] Breast metastasis from melanoma mimicking inflammatory breast cancer
    Martinez-Esteve, A.
    Alvarez-Perez, R. M.
    Caballero-Gullon, L.
    Sancho-Marquez, M. P.
    Borrego-Dorado, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 389 - 390
  • [23] Breast metastasis from melanoma mimicking inflammatory breast cancer
    A. Martínez-Esteve
    R. M. Álvarez-Pérez
    L. Caballero-Gullón
    M. P. Sancho-Márquez
    I. Borrego-Dorado
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 389 - 390
  • [24] Inflammatory Breast Cancer: Understanding the Patient Experience
    Whisenant, Meagan S.
    Alexander, Angela
    Woodward, Wendy A.
    Teshome, Mediget
    Ueno, Naoto Tada
    Williams, Loretta A.
    CANCER NURSING, 2024, 47 (01) : E65 - E72
  • [25] MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding
    Das, Swadesh K.
    Fisher, Paul B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2025, 29 (03) : 75 - 92
  • [26] Understanding susceptibility to breast cancer metastasis: the genetic approach
    Shukla, Anjali
    Alsarraj, Jude
    Hunter, Kent
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 165 - 172
  • [27] Understanding the biologic determinants of ribociclib efficacy in breast cancer
    Braso-Maristany, F.
    Palafox, M.
    Monserrat, L.
    Bellet, M.
    Oliveira, M.
    Capelan, M.
    Galvan, P.
    Martinez, D.
    Chic, N.
    Viaplana, C.
    Dienstmann, R.
    Nuciforo, P.
    Saura Manich, C.
    Prat, A.
    Serra, V.
    ANNALS OF ONCOLOGY, 2021, 32 : S27 - S27
  • [28] Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis
    Ortiz-Soto, Gabriela
    Babilonia-Diaz, Natalia S.
    Lacourt-Ventura, Mercedes Y.
    Rivera-Rodriguez, Delmarie M.
    Quinones-Rodriguez, Jailenne I.
    Colon-Vargas, Monica
    Almodovar-Rivera, Israel
    Ferrer-Torres, Luis E.
    Suarez-Arroyo, Ivette J.
    Martinez-Montemayor, Michelle M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [29] Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer
    Lauren M. Postlewait
    Mediget Teshome
    Taiwo Adesoye
    Sarah M. DeSnyder
    Bora Lim
    Henry M. Kuerer
    Isabelle Bedrosian
    Susie X. Sun
    Wendy A. Woodward
    Huong T. Le-Petross
    Vicente Valero
    Naoto T. Ueno
    Anthony Lucci
    Annals of Surgical Oncology, 2021, 28 : 8610 - 8621
  • [30] The molecular signature of breast cancer metastasis to bone
    Bahrami, Tayyeb
    Mokmeli, Sharareh
    Hossieni, Hossien
    Pourpaknia, Reza
    Makani, Zahra
    Salmaninejad, Arash
    Estiar, Mehrdad A.
    Hossieni, Ali
    Farshbaf, Alieh
    ANTI-CANCER DRUGS, 2016, 27 (09) : 824 - 831